Inquire About a Product| Product: | 1-Hydroxy-Tacrine-d4 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | D33147 | ||||||||
| Synonyms: |
Velnacrine-d4; P 83-6029A-d4; Mentane-d4; HP 029-d4; 9-Amino-1,2,3,4-tetrahydro-1-acridinol-d4 |
||||||||
| Pricing: |
|
||||||||
| Formula: | C13H10N2OD4 | ||||||||
| Enrichment: | 99.2% D | ||||||||
| Chemical Purity: | 99.7% | ||||||||
| Molecular Weight: | 218.29 | ||||||||
| Structure: |
|
||||||||
| Category: | Research Compounds | ||||||||
| Literature References: |
Wood, D.M., Ford, J.M., Roberts, C.J.C., Variability in the plasma protein binding of velnacrine (1-hydroxy tacrine hydrochloride) A potential agent for Alzheimer’s disease. European Journal of Clinical Pharmacology, 1996, 50(1):115-119.; Nordberg, A., Amberla, K., Shigeta, M., Lundqvist, H., Viitanen, M., Hellstrom-Lindahl, E., Johansson, M., Andersson, J., Hartvig, P., Lilja, A., Långström, B., Winblad, B., Long-Term Tacrine Treatment in Three Mild Alzheimer Patients: Effects on Nicotinic Receptors, Cerebral Blood Flow, Glucose Metabolism, EEG, and Cognitive Abilities. Alzheimer Disease & Associated Disorders, 1998, 12(3). |
||||||||
| MSDS: | |||||||||
| Applications: | The labeled major active metabolite of tacrine. Used as a potential Alzheimer's disease therapeutic. |